Run your pharma teams
from one shared operating system

Medical affairs, commercial, and operations work off one live picture of your centers, prescribers, patients, and the market. The moment a competitor move, a trial update, or a filing appears, it reaches the team and the account it affects. One system instead of scattered tools and reports that arrive a quarter late.

Rare disease 42
Nevaris · DACH18
Nevaris · Nordics12
Caldyra · EU6
Oncology 27
Otreva · US15
Zelmora · EU9
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
291623
291623
3061320
2741118
251815
2229613
2027310
1724
Nevaris · EU launch
CHMP opinion EC approval
Competitive landscape
Competitor readout Rival launch (est.)
GA
Field readiness
Center onboarding
One launch, its competitive landscape, and field readiness. In a single view.

Used by commercial and competitive intelligence teams across pharma and biotech

Sanofi Evonik STADA Zenith Pharma Olympe Pharma ITF

The market moves faster
than most teams can read it

01

Competitive awareness runs late

Filings, trial changes, pricing moves, and label updates are public early. By the time they reach the people who need them internally, weeks have passed.

02

Commercial knowledge is scattered

Medical affairs holds the KOL and center map. Commercial keeps orders and territory. Operations tracks payments and consents. When a strong rep leaves, months of context can leave with them.

03

Every launch is a race

In specialty and rare disease, success can rest on a handful of centers and doctors. There is little room for a decision that arrives a quarter late.

The cost of the gap between real-time market movement and quarterly decision-making shows up on the launch calendar and the P&L.

Most teams already have tools
What they don’t have is one system for the full launch workflow

A generic CRM

models accounts and contacts. It does not know what a treatment center is, how a prescriber links to a patient, or what an adverse event report requires. Your team adapts it after the fact and still fills the gaps by hand.

An enterprise platform

has the depth, but at a cost and rollout timeline few teams can absorb.

A point tool

answers one function well and leaves the other three teams working somewhere else. Buy four, and you are back to reconciling four systems by hand.

A spreadsheet

is fast and free and holds until the launch gets big enough that a single wrong cell costs a center.

Different tools, same problem

Running several of these together doesn’t solve the fragmentation. It adds more vendors, more handoffs, and more manual reconciliation. Teams still work across separate systems, with people filling the gaps between them manually.

Every signal connected to
the decision it affects

α:one models what your teams actually work with: centers, prescribers, patients, pharmacies, territories, key accounts, trials, and competitors. It links them, so a prescriber connects to a center, a center to its patients, a patient to an order, an order to a payment, and an event to a pharmacovigilance report. One object, updated once, is current everywhere.

See this on a live demo
INCOMING SIGNALS
Competitor Phase III readout posted
Reimbursement change, DE market
New KOL publication indexed
Pricing update flagged, EU5
Regulatory filing detected
Ask
Ask for a summary, deeper analysis, or the next best action.
Items needing attention

Accounts affected by this week’s signals:

PHARMACY
CITY
TERRITORY
DATE
UNITS
Apotheke im Medcenter
Crimmitschau
05
19 Jul
4
Allee Apotheke Lynen
Holzwickede
03
17 Jul
4
Rathaus Apotheke
Baunatal
06
17 Jul
3
Jasmin Apotheke
Neuwied
03
20 Jul
2
Greifenstein-Apotheke
Thum
05
20 Jul
2

Four teams. One shared view of the market.

Each team works differently. The context stays connected.

01

MEDICAL AFFAIRS

maps the KOLs, centers, and patient journey.

02

COMMERCIAL EXCELLENCE

runs the accounts, orders, territories, and forecasts.

03

OPERATIONS

keeps consents, payments, and incidents clean.

04

COMPETITIVE INTELLIGENCE

keeps the market picture live for the other three.

One shared market view

One object, updated once, is current everywhere.

Centers
Prescribers
Patients
Orders

AI agents, pharma CRM and live market signals
One system, one data layer

AI agents

The connective layer. They read across your intelligence and CRM, surface what matters, draft the reports and presentations your team used to build by hand, and flag what needs attention. You can also ask a direct question in plain language and get a structured, source-linked answer back.

CRM built for pharma

Treatment centers, HCPs, pharmacies, and patients, with orders, payments, and territory managed in one place. Not a generic CRM adapted after the fact.

Live market monitoring

Continuous tracking of competitor pipelines, clinical trials, regulatory activity, KOLs, pricing, and publications, benchmarked across sponsors and molecules.

The point is not three modules bolted together

Because they share one data layer, a competitor signal on the intelligence side can inform a territory or account decision on the CRM side, in real time, in the same platform.

The capabilities a typical CRM and a typical intelligence tool don’t have, because they weren’t built for pharma, or weren’t built together

The real pharma graph, not accounts and contacts

α:one links prescriber to center to patient to order to payment to safety event. That single connected model is why a medical insight can inform a commercial decision and an operations alert in the same system, with no export and no reconciliation. Most tools can't represent these objects at all, let alone connect them.

Evidence-weighted center scoring

Centers are scored on two axes: how much of a barrier or enabler they are to adoption, and how confident the team is in that score, from early hypothesis to strong evidence. Prioritizing a territory becomes a structured, auditable decision instead of a gut feel. Generic CRMs have no equivalent.

Automated reports and presentations

Any question you ask, or any dashboard view, can become a shareable presentation in minutes. This is the direct answer to the most common complaint about enterprise platforms: powerful data, slow manual reporting.

Order and payment automation

Order sheets are parsed automatically, payment due dates and delays are tracked against each order, and color-coded alerts flag what’s due, overdue, or missing. Late-payment discovery moves from end-of-month reconciliation toward a same-day alert, which protects cash flow before a delay becomes a loss.

Country Cockpit

Regional teams share reports, insights, and documents in one secure workspace instead of duplicating work and emailing spreadsheets across time zones. Local speed with global consistency.

WHO IT’S FOR

Built for specialty and rare disease launches
Designed around how each team works

Medical Affairs

Map KOLs and centers, compare clinical trials, plan scientific engagement, and turn field insights into clear action plans.

Commercial Excellence

Bring territories, accounts, prescriptions, visits, and forecasts into one view, with market signals connected to performance.

Operations

Keep consents, payments, adherence checks, incidents, and audit ready workflows connected to the same business records.

Competitive Intelligence

Monitor trials, filings, pricing, publications, KOLs, and competitor moves, and route source linked insights to the teams that need them.

Where connected teams matter most

Patient, center, and doctor data unified with pharmacovigilance and QM tracking brings clinical grade rigor to the teams running the launch, so a lean organization can operate with confidence without enterprise scale overhead.

Real results, across different ways teams put α:one to work

Insights

Tracking the competitive and regulatory landscape in real time through launch.

Used α:one’s competitive intelligence to support a launch team.

Hospital
Doctor
Patient
Pharmacy

Reducing onboarding-to-first-prescription time.

Used center mapping to unify tracking across thousands of treatment centers in a rare disease launch.

Reduced pharmacovigilance reporting errors after implementation.

PRICING POSTURE

Enterprise-grade capability, right-sized cost and rollout

α:one goes live in weeks, not a multi-month professional-services engagement, and it replaces a separate competitive intelligence subscription and CRM with one system.

TIME TO LIVE
Weeks, with your therapeutic area and account list loaded before kickoff.
WHAT IT REPLACES
One intelligence subscription plus one CRM, consolidated into a single contract.
HOW IT SCALES
By team size, from a single launch squad to a full commercial organization.

Questions, answered

Medical affairs, commercial, operations, and competitive intelligence teams across pharma, life sciences, and biotech, from a single product launch team to a full field organization. Each team works in its own view, off the same shared data.

α:one is designed to go live in weeks, not a multi-month rollout.

Every AI-assisted action is confirmed by a human before it’s finalized, and every action is logged. The full activity history supports your internal governance and pharmacovigilance and QM audits, and the reporting workflows are built to support your compliance work rather than replace your responsibility for it.

For most teams, yes. The core value is consolidating both into one system rather than running and reconciling two.

Pricing scales with team size and covers competitive intelligence and CRM in one system. Exact pricing is confirmed in a scoped conversation.

See α:one on your next launch, not your entire portfolio

Thirty minutes, no preparation. We walk one live market signal through α:one into a commercial decision, on the kind of launch your team is running now.

Live signal to decision, on your therapeutic area
Market signals, CRM and action plans in one place
A short reply from our team, not an automated sequence
Request your demo
Under a minute to send.

Prefer to talk? Talk to sales